Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.2K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

6.5K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.5K
Overview of Cell-Matrix Interactions01:24

Overview of Cell-Matrix Interactions

8.7K
The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...
8.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.1K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Anastomoses01:19

Anastomoses

2.1K
In human anatomy, anastomosis refers to a connection or opening between two things, particularly between blood vessels or other tubular structures. The term is derived from the Greek term 'anastomosis,' which means 'outlet' or 'opening.' This natural network of connections plays a critical role in the survival and functionality of the human body.
Anastomoses can be formed at arterial, venous, and lymphatic vessels.
Arterial Anastomosis: These occur between arteries. They...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial-derived compartments buffer outer membrane protein load during acute mitochondrial adaptation.

bioRxiv : the preprint server for biology·2026
Same author

Vacuole pH loss triggers ESCRT-dependent plasma membrane remodeling to prevent amino acid toxicity.

bioRxiv : the preprint server for biology·2026
Same author

Targeting prohibitins activates the ISR through DELE1-HRI by impairing protein import into the mitochondrial matrix.

Cell death and differentiation·2025
Same author

Alterations in lipid saturation trigger remodeling of the outer mitochondrial membrane.

Molecular biology of the cell·2025
Same author

Nutrient-Responsive Formation of Mitochondrial-Derived Structures in <i>Caenorhabditis elegans</i>.

bioRxiv : the preprint server for biology·2025
Same author

Alterations in Lipid Saturation Trigger Remodeling of the Outer Mitochondrial Membrane.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Dec 22, 2025

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

10.0K

OPA1 and Angiogenesis: Beyond the Fusion Function.

Max-Hinderk Schuler1, Adam L Hughes1

  • 1Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.

Cell Metabolism
|May 7, 2020
PubMed
Summary
This summary is machine-generated.

The mitochondrial fusion protein OPA1 drives blood vessel growth (angiogenesis) separately from its role in mitochondria. This discovery reveals OPA1 as a potential therapeutic target for controlling abnormal vascularization.

More Related Videos

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
09:03

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

1.5K
Author Spotlight: Investigating Angiogenesis Through Challenges and Innovations in Assay Development
09:16

Author Spotlight: Investigating Angiogenesis Through Challenges and Innovations in Assay Development

Published on: May 31, 2024

1.9K

Related Experiment Videos

Last Updated: Dec 22, 2025

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

10.0K
Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
09:03

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

1.5K
Author Spotlight: Investigating Angiogenesis Through Challenges and Innovations in Assay Development
09:16

Author Spotlight: Investigating Angiogenesis Through Challenges and Innovations in Assay Development

Published on: May 31, 2024

1.9K

Area of Science:

  • Mitochondrial biology
  • Vascular biology
  • Cancer research

Background:

  • Mitochondrial dynamics are crucial for cellular functions.
  • Optic Atrophy 1 (OPA1) is a key protein regulating mitochondrial fusion.
  • The role of OPA1 in processes beyond mitochondrial morphology is not fully understood.

Purpose of the Study:

  • To investigate the function of OPA1 in angiogenesis.
  • To determine if OPA1's role in angiogenesis is linked to its mitochondrial fusion activity.

Main Methods:

  • Utilized genetic models and biochemical assays.
  • Examined OPA1's impact on endothelial cell behavior and blood vessel formation in vivo and in vitro.

Main Results:

  • OPA1 promotes angiogenesis independently of its role in mitochondrial fusion.
  • OPA1 influences signaling pathways critical for vascular development.
  • Targeting OPA1 can inhibit pathological angiogenesis.

Conclusions:

  • OPA1 is a novel regulator of angiogenesis.
  • OPA1 represents a potential therapeutic target for diseases characterized by aberrant blood vessel growth, such as cancer and developmental disorders.